Vertex director receives 107 deferred stock units
SACHS BRUCE I reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
SACHS BRUCE I reported acquisition or exercise transactions in this Form 4 filing.
Vertex Pharmaceuticals director Bruce I. Sachs received a routine equity grant in the form of deferred stock units. He was awarded 107.345 deferred stock units at a reference price of $442.50 per unit, each representing one share of common stock. After this grant, Sachs holds 15,671.866 deferred stock units. According to the terms, these units are paid out in common stock upon the earliest of his board service ending, a change of control of the company, or his disability or death.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 107.345 shares
Grant/Award
1 txn
Insider
SACHS BRUCE I
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 107.345 | $442.50 | $48K |
Holdings After Transaction:
Deferred Stock Units — 15,671.866 contracts (Direct)
Footnotes (1)
- F1. Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.
Key Figures
Deferred stock units granted: 107.345 units
Grant reference price: $442.50 per unit
Total deferred units after grant: 15,671.866 units
+2 more
5 metrics
Deferred stock units granted
107.345 units
Grant of deferred stock units on April 15, 2026
Grant reference price
$442.50 per unit
Reference price used for the deferred stock unit award
Total deferred units after grant
15,671.866 units
Director holdings in deferred stock units following the transaction
Underlying common stock
107.345 shares
Common shares represented by the new deferred stock units
Conversion price
$0.00
Deferred stock units have no separate exercise price
Key Terms
Deferred Stock Units, change of control, board of directors, Grant, award, or other acquisition
4 terms
Deferred Stock Units financial
"Each deferred stock unit represents one share of common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
change of control financial
"upon the earliest to occur of (i) termination ... (ii) a change of control of our company"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
board of directors financial
"termination of Mr. Sachs' service on our board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VRTX director Bruce Sachs report on this Form 4?
Bruce I. Sachs reported receiving a grant of 107.345 deferred stock units tied to Vertex common stock. This is a compensation-related equity award, not an open-market purchase or sale, and reflects part of his ongoing director compensation at Vertex Pharmaceuticals.
How many Vertex deferred stock units does Bruce Sachs hold after this transaction?
Following the April 15 grant, Bruce Sachs holds a total of 15,671.866 deferred stock units. Each unit corresponds to one share of Vertex common stock, giving a clear view of his accumulated director equity awards linked to VRTX stock performance over time.
At what price were Bruce Sachs’s new Vertex deferred stock units valued?
The 107.345 deferred stock units granted to Bruce Sachs were valued at $442.50 per unit. This figure represents the reference price used for the award calculation and helps indicate the notional value of this portion of his director equity compensation at grant.
What does each deferred stock unit for VRTX represent for Bruce Sachs?
Each deferred stock unit represents one share of Vertex common stock for Bruce Sachs. Instead of immediate stock delivery, these units accumulate and are later settled in actual common shares, aligning director compensation with long-term changes in Vertex’s share price performance.
When will Bruce Sachs receive Vertex common stock from these deferred stock units?
The deferred stock units are paid out in Vertex common stock upon the earliest of three events: Bruce Sachs leaving the board, a change of control of the company, or his disability or death. These conditions define when the deferred compensation becomes actual share ownership.
Is Bruce Sachs’s Form 4 for VRTX a buy or a routine award?
The Form 4 reflects a routine award, not an open-market stock purchase. Bruce Sachs acquired 107.345 deferred stock units as a grant, categorized as a “Grant, award, or other acquisition,” consistent with compensation practices rather than discretionary trading in Vertex shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
